Who
Seth Harmon
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Viridian Therapeutics.
In numbers
- Trades disclosed
- 15
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 10 Nov 2023
- Last trade
- 3 Mar 2026
- Last filed
- 9 Mar 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Mar 2026filed 9 Mar 2026 | VRDN Viridian TherapeuticsBiotechnology | SEC FORM 4 Code F | $61K2,031 at $30.19 | filing |
| 3 Mar 2026filed 9 Mar 2026 | VRDN Viridian TherapeuticsBiotechnology | SEC FORM 4 Code F | $61K2,031 at $30.19 | filing |
| 3 Mar 2026filed 4 Mar 2026 | VRDN Viridian TherapeuticsBiotechnology | SEC FORM 4 Code M | —6,267 | filing |
| 3 Mar 2026filed 4 Mar 2026 | VRDN Viridian TherapeuticsBiotechnology | SEC FORM 4 Code F | $61K2,091 at $29.32 | filing |
| 3 Mar 2026filed 4 Mar 2026 | VRDN Viridian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —6,267 at $0.00 | filing |
| 3 Mar 2026filed 4 Mar 2026 | VRDN Viridian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —6,267 at $0.00 | filing |
| 3 Mar 2026filed 4 Mar 2026 | VRDN Viridian TherapeuticsBiotechnology | SEC FORM 4 Code M | —6,267 | filing |
| 3 Mar 2026filed 4 Mar 2026 | VRDN Viridian TherapeuticsBiotechnology | SEC FORM 4 Code F | $61K2,091 at $29.32 | filing |
| 2 Mar 2026filed 4 Mar 2026 | VRDN Viridian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —102,850 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | VRDN Viridian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —102,850 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | VRDN Viridian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,550 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | VRDN Viridian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,550 at $0.00 | filing |
| 3 Mar 2025filed 4 Mar 2025 | VRDN Viridian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —150,407 at $0.00 | filing |
| 3 Mar 2025filed 4 Mar 2025 | VRDN Viridian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,068 at $0.00 | filing |
| 10 Nov 2023filed 13 Nov 2023 | VRDN Viridian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —270,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.